Shuangcui Wang
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Decoupled dynamics of absolute and relative lymphocyte counts and age-polarized CD4+/CD8+ ratio in infants versus older adults.
Journal: Frontiers in immunology
Published: March 25, 2025
Identification of cellular senescence-associated genes for predicting the diagnosis, prognosis and immunotherapy response in lung adenocarcinoma via a 113-combination machine learning framework.
Journal: Discover oncology
Published: December 10, 2024
PI3K/AKT/mTOR and PD‑1/CTLA‑4/CD28 pathways as key targets of cancer immunotherapy (Review).
Journal: Oncology letters
Published: June 21, 2024
Myocardial Ischemia/Reperfusion Injury: Mechanism and Targeted Treatment for Ferroptosis.
Journal: Anatolian journal of cardiology
Published: February 19, 2024
CircRNA Interference Pathway: A New Target for Intervention in Different Stages of Heart Failure.
Journal: Current topics in medicinal chemistry
Published: January 31, 2024
Immune signature and phagocytosis of circulating DC subsets in healthy adults during aging.
Journal: International immunopharmacology
Published: November 11, 2023
Prognostic significance of blood-based PD-L1 analysis in patients with non-small cell lung cancer undergoing immune checkpoint inhibitor therapy: a systematic review and meta-analysis.
Journal: World journal of surgical oncology
Published: May 24, 2023
The DC-T cell axis is an effective target for the treatment of non-small cell lung cancer.
Journal: Immunity, inflammation and disease
Published: April 18, 2023
Sacubitril/valsartan ameliorates cardiac function and ventricular remodeling in CHF rats via the inhibition of the tryptophan/kynurenine metabolism and inflammation.
Journal: Scientific reports
Published: March 26, 2023
Sacubitril/valsartan: research progress of multi-channel therapy for cardiorenal syndrome.
Journal: Frontiers in pharmacology
Published: February 16, 2023
NLRP3 inflammasome as a novel therapeutic target for heart failure.
Journal: Anatolian journal of cardiology
Published: February 22, 2022
Shengmai Yin formula exerts cardioprotective effects on rats with chronic heart failure via regulating Linoleic Acid metabolism.
Journal: Prostaglandins & other lipid mediators
Published: September 18, 2021
Last Updated: 09/26/2026